TY - JOUR
T1 - Atrial Tachycardias After Surgical Atrial Fibrillation Ablation
T2 - Clinical Characteristics, Electrophysiological Mechanisms, and Ablation Outcomes From a Large, Multicenter Study
AU - Gopinathannair, Rakesh
AU - Mar, Philip L.
AU - Afzal, Muhammad Rizwan
AU - Di Biase, Luigi
AU - Tu, Yixi
AU - Lakkireddy, Thanmay
AU - Trivedi, Jaimin R.
AU - Slaughter, Mark S.
AU - Natale, Andrea
AU - Lakkireddy, Dhanunjaya
N1 - Publisher Copyright:
© 2017 American College of Cardiology Foundation
PY - 2017/11/7
Y1 - 2017/11/7
N2 - Objectives: The clinical characteristics, electrophysiological mechanisms, and ablation outcomes of post-surgical atrial fibrillation ablation (SAFA) atrial tachycardias (ATs) have not been studied in a large, multicenter cohort. Background: ATs are often seen following SAFA. Methods: Analysis was performed on 137 patients (age, 62 ± 10 years; 74% male) who underwent catheter ablation for symptomatic post-SAFA AT from 2004 to 2013 at 3 high-volume institutions in the United States. Results: A total of 137 patients had 149 ATs that were mapped; 103 (69%) had a left atrial (LA) origin and 46 (31%) had a right atrial origin. Of the 149, a total of 44 (30%) had a focal mechanism, with 29 (66%) having an LA origin, with 53% localized to LA posterior wall. Of the 105 re-entrant ATs, 74 (71%) were of LA origin. The predominant circuits were cavotricuspid isthmus (n = 25), perimitral (n = 19), LA roof (n = 17), left pulmonary veins (n = 13), right pulmonary vein/LA septum (n = 12), and LA appendage (n = 7). A total of 93% of patients had ≥1 pulmonary vein reconnection requiring reisolation. Catheter ablation resulted in termination and noninducibility of 97% of right atrial and 93% of LA ATs. Over a 12-month follow-up, 80% of patients were free of any AT or AF. Conclusions: In this large multicenter cohort of post-SAFA ATs, most were of LA origin, with macro–re-entry being the most common arrhythmia mechanism. Wide variability in location of AT circuits was seen in both right atrial and LA and likely reflects underlying arrhythmogenic substrate and differences in modified SAFA techniques. Catheter ablation was highly successful in eliminating the culprit AT with favorable long-term outcomes.
AB - Objectives: The clinical characteristics, electrophysiological mechanisms, and ablation outcomes of post-surgical atrial fibrillation ablation (SAFA) atrial tachycardias (ATs) have not been studied in a large, multicenter cohort. Background: ATs are often seen following SAFA. Methods: Analysis was performed on 137 patients (age, 62 ± 10 years; 74% male) who underwent catheter ablation for symptomatic post-SAFA AT from 2004 to 2013 at 3 high-volume institutions in the United States. Results: A total of 137 patients had 149 ATs that were mapped; 103 (69%) had a left atrial (LA) origin and 46 (31%) had a right atrial origin. Of the 149, a total of 44 (30%) had a focal mechanism, with 29 (66%) having an LA origin, with 53% localized to LA posterior wall. Of the 105 re-entrant ATs, 74 (71%) were of LA origin. The predominant circuits were cavotricuspid isthmus (n = 25), perimitral (n = 19), LA roof (n = 17), left pulmonary veins (n = 13), right pulmonary vein/LA septum (n = 12), and LA appendage (n = 7). A total of 93% of patients had ≥1 pulmonary vein reconnection requiring reisolation. Catheter ablation resulted in termination and noninducibility of 97% of right atrial and 93% of LA ATs. Over a 12-month follow-up, 80% of patients were free of any AT or AF. Conclusions: In this large multicenter cohort of post-SAFA ATs, most were of LA origin, with macro–re-entry being the most common arrhythmia mechanism. Wide variability in location of AT circuits was seen in both right atrial and LA and likely reflects underlying arrhythmogenic substrate and differences in modified SAFA techniques. Catheter ablation was highly successful in eliminating the culprit AT with favorable long-term outcomes.
KW - MAZE procedure
KW - atrial flutter
KW - atrial tachycardia
KW - catheter ablation
KW - surgical atrial fibrillation ablation
UR - http://www.scopus.com/inward/record.url?scp=85020017846&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020017846&partnerID=8YFLogxK
U2 - 10.1016/j.jacep.2017.02.018
DO - 10.1016/j.jacep.2017.02.018
M3 - Article
C2 - 29759784
AN - SCOPUS:85020017846
SN - 2405-5018
VL - 3
SP - 865
EP - 874
JO - JACC: Clinical Electrophysiology
JF - JACC: Clinical Electrophysiology
IS - 8
ER -